QQ客服 官方微博 反馈留言

	MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1
	Sun, Y.; Cao, F-L; Qu, L-L; Wang, Z-M; Liu, X-Y
刊名	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
	2019
卷号	23期号:4页码:1459-1467
关键词	MEG3 Liver cancer Cell proliferation Cell invasion AP1G1
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547846
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Dept Med Oncol, Qingdao, Peoples R China. 2.Shandong Univ, Qilu Hosp, De
推荐引用方式 GB/T 7714	Sun, Y.,Cao, F-L,Qu, L-L,et al. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,2019,23(4):1459-1467.
APA	Sun, Y.,Cao, F-L,Qu, L-L,Wang, Z-M,&Liu, X-Y.(2019).MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,23(4),1459-1467.
MLA	Sun, Y.,et al."MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 23.4(2019):1459-1467.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。